UltraSight
Series BIsraelMay 2021
UltraSight raised €11M in a Series B round in May 2021. The company is based in Israel. Investors in the round: Atain Specialty Insurance, Weizmann Institute of Science, Yozma Group Korea. Data as of Nov 2026.
Amount raised
€11M
€10,723,418
Native amount
13,000,000 USD
Stage
Series B
series b
Investors
3
Provenance & confidence
Low confidenceAmount
13,000,000 USD
ECB-at-date → €11M · rate 1.2123 on 2021-05-14
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
3 namedDate
May 2021
Round type
series b
Amount (EUR)
€11M
Other rounds
same companyThis is the company's only recorded round.
Related news
- Israeli AI cardiac ultrasound co UltraSight raises $13men.globes.co.il · 2021-05